You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 203752

✉ Email this page to a colleague

NDA 203752 describes MINIVELLE, which is a drug marketed by Noven and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the MINIVELLE profile page.

The generic ingredient in MINIVELLE is estradiol. There are seventy-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the estradiol profile page.

Summary for 203752

Tradename:	MINIVELLE
Applicant:	Noven
Ingredient:	estradiol
Patents:	4

Pharmacology for NDA: 203752

Mechanism of Action	Estrogen Receptor Agonists

Medical Subject Heading (MeSH) Categories for 203752

Estrogens

Suppliers and Packaging for NDA: 203752

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752	NDA AUTHORIZED GENERIC	A-S Medication Solutions	50090-7610	50090-7610-0	8 POUCH in 1 CARTON (50090-7610-0) / 1 d in 1 POUCH
MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752	NDA AUTHORIZED GENERIC	Noven Therapeutics, LLC	68968-3410	68968-3410-8	8 POUCH in 1 CARTON (68968-3410-8) / 1 d in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	0.0375MG/24HR
Approval Date:	Oct 29, 2012	TE:	AB3	RLD:	Yes
Patent:	⤷ Get Started Free	Patent Expiration:	Jul 4, 2030	Product Flag?	Y	Substance Flag?	Y	Delist Request?
Patent:	⤷ Get Started Free	Patent Expiration:	Jul 10, 2028	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	A METHOD FOR ADMINISTERING ESTRADIOL COMPRISING A MONOLITHIC TRANSDERMAL DRUG DELIVERY SYSTEM CONSISTING OF (I) A BACKING LAYER AND (II) A SINGLE ADHESIVE POLYMER MATRIX LAYER AS CLAIMED IN US PATENT NO. 9730900
Patent:	⤷ Get Started Free	Patent Expiration:	Jul 10, 2028	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 203752

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Noven	MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752-002	Oct 29, 2012	⤷ Get Started Free	⤷ Get Started Free
Noven	MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752-004	Oct 29, 2012	⤷ Get Started Free	⤷ Get Started Free
Noven	MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752-002	Oct 29, 2012	⤷ Get Started Free	⤷ Get Started Free
Noven	MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752-003	Oct 29, 2012	⤷ Get Started Free	⤷ Get Started Free
Noven	MINIVELLE	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	203752-001	Oct 29, 2012	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.